Globus Medical, Inc.
Globus Medical, Inc. (GMED) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GMED · as of Sep 30, 2024
Ownership Breakdown
462
Institutional Holders
▲ 3 vs Q2
$7.74B
Total Inst. Value
▲ $10.30M vs Q2
134.86M
Shares Outstanding
freeFloat 99.29%
108.14M
13F Shares Held
▼ 4.68M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GMED largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC surgical & medical instruments & apparatus | 10.62M | 7.83% | 7.83% | $760.01B | Nov 13, 2024 | ▼ 50.3K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 10.27M | 7.58% | 7.58% | $734.98B | Nov 13, 2024 | NEW |
JANUS HENDERSON GROUP PLC surgical & medical instruments & apparatus | 7.00M | 5.16% | 5.16% | $500.61B | Nov 14, 2024 | ▼ 387.2K |
STATE STREET CORP surgical & medical instruments & apparatus | 3.57M | 2.63% | 2.63% | $255.45B | Nov 14, 2024 | ▲ 81.4K |
JPMORGAN CHASE & CO surgical & medical instruments & apparatus | 2.60M | 1.92% | 1.92% | $186.35B | Dec 26, 2024 | ▼ 31.1K |
WELLINGTON MANAGEMENT GROUP LLP surgical & medical instruments & apparatus | 2.58M | 1.90% | 1.90% | $184.47B | Nov 14, 2024 | ▼ 631.2K |
BURGUNDY ASSET MANAGEMENT LTD. surgical & medical instruments & apparatus | 2.57M | 1.90% | 1.90% | $184.20B | Nov 12, 2024 | ▲ 59.9K |
BANK OF NEW YORK MELLON CORP surgical & medical instruments & apparatus | 2.36M | 1.74% | 1.74% | $168.91B | Nov 12, 2024 | ▼ 252.6K |
SCULPTOR CAPITAL LP surgical & medical instruments & apparatus | 2.21M | 1.63% | 1.63% | $158.16B | Nov 14, 2024 | — held |
HAWK RIDGE CAPITAL MANAGEMENT LP surgical & medical instruments & apparatus | 2.18M | 1.61% | 1.61% | $155.77B | Nov 14, 2024 | ▼ 192.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
15
Increased
+2.26M shares3
New Positions
first time holders30
Decreased
−5.47M shares0
Sold Out
fully exitedNet shares change (top 50)
3.20M
+2.26M / −5.47M
Net new holders
-12
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GMED insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
16
Buy transactions
7
Sell transactions
2.29
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Huller Kelly EVP, GC, Corporate Secretary | Feb 25, 2026 | Sale | 20,000 | $94.50 | $1.89M | 0 | Form 4 ↗ |
Huller Kelly EVP, GC, Corporate Secretary | Feb 12, 2026 | Sale | 10,000 | $87.67 | $876.7K | 0 | Form 4 ↗ |
Norwalk Leslie V director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
Pfeil Keith W President, CEO | Jan 21, 2026 | Award | 100,000 | $94.15 | $9.41M | 100.0K | Form 4 ↗ |
Kline Kyle Senior Vice President, CFO | Jan 21, 2026 | Award | 30,000 | $94.15 | $2.82M | 30.0K | Form 4 ↗ |
Paul David C Executive Chairman | Jan 21, 2026 | Award | 100,000 | $94.15 | $9.41M | 100.0K | Form 4 ↗ |
Douglas Robert Andrew director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
Lemaitre Dan director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
RHOADS ANN D director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
TOBIN JAMES R director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Globus Medical, Inc. (GMED) is primarily owned by institutional investors, who hold approximately 80.2% of total shares outstanding. Company insiders own approximately 0.71%, while retail and public investors account for the remaining 19.10%.
The largest institutional shareholder of Globus Medical, Inc. is VANGUARD GROUP INC, holding approximately 10.62 million shares — equal to 7.83% of outstanding shares — as of September 30, 2024.
A total of 462 institutional investors currently hold GMED stock, with a combined institutional value of approximately $7.74 billion as of the most recent 13F filing period.
Frequently asked questions
GMED ownershipGlobus Medical, Inc. (GMED) is primarily owned by institutional investors, who hold approximately 80.2% of shares. The largest shareholder is VANGUARD GROUP INC with a 7.83% stake. Company insiders hold 0.71%. Data sourced from SEC Form 13F as of September 30, 2024.